305 related articles for article (PubMed ID: 25001638)
1. Episcleral, intrascleral, and suprachoroidal routes of ocular drug delivery - recent research advances and patents.
Gilger BC; Mandal A; Shah S; Mitra AK
Recent Pat Drug Deliv Formul; 2014; 8(2):81-91. PubMed ID: 25001638
[TBL] [Abstract][Full Text] [Related]
2. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging.
Kim SH; Galbán CJ; Lutz RJ; Dedrick RL; Csaky KG; Lizak MJ; Wang NS; Tansey G; Robinson MR
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):808-14. PubMed ID: 17251481
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
Lakhani P; Patil A; Majumdar S
Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
[TBL] [Abstract][Full Text] [Related]
4. MRI in ocular drug delivery.
Li SK; Lizak MJ; Jeong EK
NMR Biomed; 2008 Nov; 21(9):941-56. PubMed ID: 18186077
[TBL] [Abstract][Full Text] [Related]
5. A review on recent drug delivery systems for posterior segment of eye.
Nayak K; Misra M
Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
[TBL] [Abstract][Full Text] [Related]
6. Recent patents on ocular drug delivery systems.
Conway BR
Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.
Gaballa SA; Kompella UB; Elgarhy O; Alqahtani AM; Pierscionek B; Alany RG; Abdelkader H
Drug Deliv Transl Res; 2021 Jun; 11(3):866-893. PubMed ID: 32901367
[TBL] [Abstract][Full Text] [Related]
9. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Topical Ocular Drug Delivery.
Yellepeddi VK; Palakurthi S
J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
[TBL] [Abstract][Full Text] [Related]
11. Recent overview of ocular patents.
Gaudana RJ; Gokulgandhi MR; Boddu SH; Mitra AK
Recent Pat Drug Deliv Formul; 2012 Aug; 6(2):95-106. PubMed ID: 22493994
[TBL] [Abstract][Full Text] [Related]
12. Patent perspectives for corticosteroids based ophthalmic therapeutics.
Suresh PK; Sah AK
Recent Pat Drug Deliv Formul; 2014; 8(3):206-23. PubMed ID: 25020063
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.
Bravo-Osuna I; Andrés-Guerrero V; Pastoriza Abal P; Molina-Martínez IT; Herrero-Vanrell R
Drug Deliv Transl Res; 2016 Dec; 6(6):686-707. PubMed ID: 27766598
[TBL] [Abstract][Full Text] [Related]
15. Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry.
Tyagi P; Kadam RS; Kompella UB
PLoS One; 2012; 7(10):e48188. PubMed ID: 23118950
[TBL] [Abstract][Full Text] [Related]
16. The suprachoroidal space as a route of administration to the posterior segment of the eye.
Chiang B; Jung JH; Prausnitz MR
Adv Drug Deliv Rev; 2018 Feb; 126():58-66. PubMed ID: 29545195
[TBL] [Abstract][Full Text] [Related]
17. Ocular drug delivery.
Ghate D; Edelhauser HF
Expert Opin Drug Deliv; 2006 Mar; 3(2):275-87. PubMed ID: 16506953
[TBL] [Abstract][Full Text] [Related]
18. Recent patents and advances in ophthalmic drug delivery.
Janoria KG; Hariharan S; Dasari CR; Mitra AK
Recent Pat Drug Deliv Formul; 2007; 1(2):161-70. PubMed ID: 19075883
[TBL] [Abstract][Full Text] [Related]
19. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical Manipulations for Ocular Drug Delivery.
Tiwary AK
Recent Pat Drug Deliv Formul; 2019; 13(4):244-245. PubMed ID: 32400325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
